Labcorp (LH)CEO sold ~$1.5M
Adam H Schechter, CEO at Labcorp, sold ~$1.5M of Labcorp shares.
- ~$1.5M
- Approx. value · 5,273 sh @ $284.38
- 87K
- Holds after · shares reported
- Traded
- Feb 11, 2026
- Filed
- Feb 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 9, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Mark Schroeder, the Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer of Labcorp Holdings Inc. (the “Company”), notified the Company of his intention to retire, effective on April 1, 2026.”
- Jan 28, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Jan 28, 2026CongressDisclosed purchase of LH — reported range $1,001 - $15,000
- Feb 4, 2026CongressDisclosed purchase of LH — reported range $1,001 - $15,000
- Feb 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Labcorp Holdings Inc. (the “Company”) today announced that on February 6, 2026, the Company’s Board of Directors (the “Board”) appointed John H. Sampson, M.D., Ph.D., as a member of the Board, effective February 9, 2026.”
- Feb 9, 2026InsiderOfficer sold ~$24K of LH shares in the open market
- Feb 10, 2026InsiderOfficer sold ~$25K of LH shares in the open market
- Feb 11, 2026 · this disclosureInsiderCEO sold ~$1.5M of LH shares in the open market
What came next
- Feb 11, 2026CongressDisclosed purchase of LH — reported range $1,001 - $15,000
- Feb 12, 2026InsiderOfficer sold ~$25K of LH shares in the open market
- Feb 17, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 19, 2026InsiderOfficer sold ~$185K of LH shares in the open market
- Feb 24, 2026InsiderOfficer sold ~$429K of LH shares in the open market
- Feb 27, 2026InsiderOfficer sold ~$156K of LH shares in the open market
- Mar 3, 2026Insider · Their largest sale since 2018CEO sold ~$2.44M of LH shares in the open market
- Mar 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026Insider · 2 peopleInsiders: 2 sales (~$660K)
- Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
- May 11, 2026InsiderCEO sold ~$1.5M of LH shares in the open market
- Jun 8, 2026InsiderOfficer sold ~$201K of LH shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Labcorp
For Labcorp, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 13 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.
Other recent filings by Adam H Schechter, President & CEO
- SEC Form 4 at Labcorp (LH)Aug 12, 2026
- SEC Form 4 at Labcorp (LH)May 13, 2026
- SEC Form 4 at Labcorp (LH)Mar 5, 2026
- SEC Form 4 at Labcorp (LH)Nov 13, 2025
- SEC Form 4 at Labcorp (LH)Aug 13, 2025
The full history of Adam H Schechter, President & CEO is on the profile page.
How this filing works
Other disclosures at Labcorp
- House Clerk periodic transaction reportSep 9, 2026
- House Clerk periodic transaction reportSep 9, 2026
- House Clerk periodic transaction reportSep 9, 2026
- House Clerk periodic transaction reportSep 9, 2026
- SEC Form 4Aug 18, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its LH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
